DHR
Danaher Corporation
NYQ
$176.11
-3.76
(-2.09%)
Neutral · +0.19σ
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$124.6B
P/E ttm
34.1
Fwd P/E
19.3
Beta
0.84
Day range
$176.11
52w range
$160.93 – $242.80
Avg vol
4.5M
RSI(2)
22.8
ROE
7.1%
Net mgn
14.9%
FCF mgn
18.4%
Debt/Eq
0.37
Div yld
89.00%
Sector
Healthcare
Industry
Diagnostics & Research
Next earn
2026-07-21
Matrix setup grades
Long
—
score 9 · tech 9 / 80 · support 0 / 20
above KC1 lower, +0.21 ATR from EMA21 · no notable pattern
Short
—
score 18 · tech 18 / 80 · support 0 / 20
below KC1 upper, +0.21 ATR from EMA21 · no notable pattern
- · Stochastic bear cross in overbought
- · Aligned with weak downtrend
Options · swing
See more →
CALL
$180
2026-07-17
$6.65
PUT
$175
2026-07-17
$7.45
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-21
- EPS (act / est)
- 2.06 / 1.94
- Surprise
- +6.5%
- Next report
- 2026-07-21
About
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and inte…